Dalton Announces Collaboration Developing a Promising Broad Spectrum…

Dalton signs manufacturing agreement for a potent antiviral agent that has shown to be effective in animal studies against avian influenza virus, ebola and alphavirus infections

(PRWeb April 24, 2012)

Read the full story at http://www.prweb.com/releases/Dalton/antiviral-agent/prweb9354323.htm

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog